批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2017/02/23 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/12/03 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
2010/01/14 |
SUPPL-12(补充) |
Approval |
Labeling |
|
|
|
2009/08/18 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
2009/07/15 |
SUPPL-14(补充) |
Approval |
Labeling |
|
|
|
2009/04/30 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
2008/12/18 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
2008/09/03 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
2006/06/07 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
2004/04/20 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
1998/11/16 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/02/27 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:PROCHLORPERAZINE MALEATE 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
040185 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Discontinued |
No |
No |
AB |
1996/10/28
|
NORVIUM BIOSCIENCE |
040268 |
001 |
ANDA |
PROCOMP |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
1998/02/27
|
JUBILANT CADISTA |
216202 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2022/06/13
|
NOVITIUM PHARMA |
216495 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2022/08/08
|
ZYDUS LIFESCIENCES |
216595 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2023/03/17
|
GLENMARK PHARMS LTD |
217478 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2023/04/04
|
BIONPHARMA |
216598 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2023/04/17
|
AMNEAL |
218515 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2024/05/09
|
AJANTA PHARMA LTD |
218912 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2024/09/30
|
LEADING |
活性成分:PROCHLORPERAZINE MALEATE 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
040185 |
001 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Discontinued |
No |
No |
AB |
1996/10/28
|
NORVIUM BIOSCIENCE |
040268 |
002 |
ANDA |
PROCOMP |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
Yes |
AB |
1998/02/27
|
JUBILANT CADISTA |
216202 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2022/06/13
|
NOVITIUM PHARMA |
216495 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2022/08/08
|
ZYDUS LIFESCIENCES |
216595 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2023/03/17
|
GLENMARK PHARMS LTD |
217478 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2023/04/04
|
BIONPHARMA |
216598 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2023/04/17
|
AMNEAL |
218515 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2024/05/09
|
AJANTA PHARMA LTD |
218912 |
002 |
ANDA |
PROCHLORPERAZINE MALEATE |
PROCHLORPERAZINE MALEATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2024/09/30
|
LEADING |